Global Information
회사소개 | 문의 | 비교리스트

Vichem Chemie Research Ltd. : 제품 파이프라인 리뷰

Vichem Chemie Research Ltd - Product Pipeline Review - 2016

리서치사 Global Markets Direct
발행일 2016년 12월 상품 코드 293923
페이지 정보 영문 32 Pages
가격
US $ 1,500 ₩ 1,812,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,625,000 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,438,000 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


Vichem Chemie Research Ltd. : 제품 파이프라인 리뷰 Vichem Chemie Research Ltd - Product Pipeline Review - 2016
발행일 : 2016년 12월 페이지 정보 : 영문 32 Pages

Vichem Chemie Research Ltd.는 키나아제 저해제를 이용한 신호전달 요법 연구개발에 주력하고 있는 바이오테크놀러지 연구 기업입니다. 키나아제 저해제 라이브러리, In Vitro Biology, ADMET 최적화, Drug Discovery 표적 단백질 등 다양한 서비스를 제공하고 있습니다.

Vichem Chemie Research Ltd.의 치료제 개발 파이프라인 현황과 각 개발 단계 비교 분석, 표적·작용기전·투여 경로·분자 종류별 치료제 평가, 후기 단계 및 중지된 프로젝트 관련 정보 등을 전해드립니다.

Vichem Chemie Research Ltd. : 기본 정보

  • Vichem Chemie Research Ltd. : 개요
  • 주요 정보
  • 기업 정보

Vichem Chemie Research Ltd. : R&D 개요

  • 주요 치료 범위

Vichem Chemie Research Ltd. : 파이프라인 리뷰

  • 개발 단계별 파이프라인 제품
  • 단일요법(Monotherapy) 제품
  • 공동 개발 제품
    • 공동 개발 제품/병용요법 모달리티

Vichem Chemie Research Ltd. : 파이프라인 제품 상황 개요

  • 초기 단계 파이프라인 제품
    • 전임상 단계 제품/병용요법 모달리티
    • Drug Discovery 단계 제품/병용요법 모달리티

Vichem Chemie Research Ltd. : 치료제 개요

  • Small Molecule for Central Nervous System and Autoimmune Disorders
  • Small Molecules to Inhibit CDK9 for HIV-1 Infection
  • VID-45110
  • BBH-7
  • BTP-15
  • Small Molecule to Antagonize VEGFR2 for
  • Undisclosed Indication
  • Small Molecule to Inhibit EGFR for Non-Small Cell Lung Cancer and Lung Adenocarcinoma
  • Small molecule to Inhibit FLT3 for Acute Myeloid Leukemia
  • Small Molecule to Inhibit PLK1 for Cancer and Bacterial Infections
  • Small Molecule to Inhibit ROCK2 for Undisclosed Indication
  • Small Molecules for Chronic Heart Failure
  • Small Molecules for Escherichia Coli Infections
  • Small Molecules for Multiple Myeloma
  • Small Molecules to Antagonize HGFR and EGFR for Oncology
  • Small Molecules to Antagonize Pan FGFR for Oncology
  • Small Molecules to Antagonize PDGFR-beta for Oncology
  • Small Molecules to Inhibit Aurora A Kinase for Oncology
  • Small Molecules to Inhibit Aurora B Kinase for Oncology
  • Small Molecules to Inhibit CDK4 for Oncology
  • VCC-405567
  • VCC-668662

Vichem Chemie Research Ltd. : 파이프라인 분석

  • 표적별
  • 분자 종류별
  • 작용기전별

Vichem Chemie Research Ltd. : 휴지 상태인 프로젝트

Vichem Chemie Research Ltd. : 본사와 자회사 소재지

부록

도표

LSH 16.01.18

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Summary:

Global Markets Direct's, 'Vichem Chemie Research Ltd - Product Pipeline Review - 2016', provides an overview of the Vichem Chemie Research Ltd's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Vichem Chemie Research Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

  • The report provides a snapshot of the pipeline therapeutic landscape of Vichem Chemie Research Ltd
  • The report provides overview of Vichem Chemie Research Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Vichem Chemie Research Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Vichem Chemie Research Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy:

  • Evaluate Vichem Chemie Research Ltd's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Vichem Chemie Research Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Vichem Chemie Research Ltd's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Vichem Chemie Research Ltd Snapshot
    • Vichem Chemie Research Ltd Overview
    • Key Facts
  • Vichem Chemie Research Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Vichem Chemie Research Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Vichem Chemie Research Ltd - Pipeline Products Glance
    • Vichem Chemie Research Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Vichem Chemie Research Ltd - Drug Profiles
    • BBH-7 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • BTP-15 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule for Oncology - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule for Tuberculosis - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small molecule to Inhibit FLT3 for Acute Myeloid Leukemia - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules for Melanoma - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit CDK9 for HIV-1 Infection - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit IRS-1 for Type 2 Diabetes - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit Pan FGFR for Oncology - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • VCC-234718 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Vichem Chemie Research Ltd - Pipeline Analysis
    • Vichem Chemie Research Ltd - Pipeline Products by Target
    • Vichem Chemie Research Ltd - Pipeline Products by Molecule Type
    • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action
  • Vichem Chemie Research Ltd - Dormant Projects
  • Vichem Chemie Research Ltd - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Vichem Chemie Research Ltd, Key Facts
  • Vichem Chemie Research Ltd - Pipeline by Indication, 2016
  • Vichem Chemie Research Ltd - Pipeline by Stage of Development, 2016
  • Vichem Chemie Research Ltd - Monotherapy Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Partnered Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Partnered Products/ Combination Treatment Modalities, 2016
  • Vichem Chemie Research Ltd - Preclinical, 2016
  • Vichem Chemie Research Ltd - Discovery, 2016
  • Vichem Chemie Research Ltd - Pipeline by Target, 2016
  • Vichem Chemie Research Ltd - Pipeline by Molecule Type, 2016
  • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action, 2016
  • Vichem Chemie Research Ltd - Dormant Developmental Projects,2016

List of Figures

  • Vichem Chemie Research Ltd - Pipeline by Top 10 Indication, 2016
  • Vichem Chemie Research Ltd - Pipeline by Stage of Development, 2016
  • Vichem Chemie Research Ltd - Monotherapy Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Pipeline by Target, 2016
  • Vichem Chemie Research Ltd - Pipeline by Molecule Type, 2016
  • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action, 2016
Back to Top
전화 문의
F A Q